Beyond Batten Disease Foundation
1 clinical trials · Sponsor
◉ Watch Beyond Batten Disease Foundation
| Record | Firm | Date |
|---|---|---|
| An Open-label Safety, Pharmacokinetic, and Efficacy Study of Miglustat for the Treatment of Subjects With Batten Ceroid Lipofuscinosis, Neuronal 3 (CLN3) Disease (NCT05174039) | Beyond Batten Disease Foundation | 2022-03-10 |
Track Beyond Batten Disease Foundation automatically
Every clearance here is in the API, with alerts when new ones post.